Dr Mark Prentice, Consultant Clinical Oncologist
Dr Mark Prentice
Consultant Clinical Oncologist
Dr Mark Prentice MBChB BSC(Hons) AKC MRCP FRCR
Consultant Clinical Oncologist
Dr Mark Prentice
Consultant Clinical Oncologist MBChB BSC(Hons) AKC MRCP FRCR

Areas of expertise
- Bladder cancer
- Prostate cancer
- Renal cancer
- Uro-oncology - prostate
- Rradio-ligand therapy

About Dr Mark Prentice
GMC number: 6160554
Year qualified: 2007
Place of primary qualification: Leicester Warwick Medical School
Dr Mark Prentice is a distinguished consultant specialising in uro-oncology, focusing on prostate, bladder, and renal cancers. Dr Prentice is highly regarded for his expertise in novel radiotherapy techniques, radio-ligand therapy, and the hormonal manipulation of prostate cancer.
In addition to his clinical practice, Dr Prentice is deeply committed to the management of older people with cancer, ensuring they receive tailored and compassionate care. He is the principal investigator for multiple clinical trials, contributing significantly to advancements in cancer treatment. His work has also led to the development of international guidelines on prostate cancer management, reflecting his dedication to improving patient outcomes globally.
Dr Prentice's roles extend beyond patient care; he is actively involved in research and education, mentoring the next generation of medical professionals. His interests in innovative treatment methods and comprehensive cancer care make him a leading figure in the field of uro-oncology.
Areas of expertise
- Bladder cancer
- Hormonal manipulation of prostate cancer
- Management of older people with cancer
- Prostate cancer
- Renal cancer
- Rradio-ligand therapy
- Uro-oncology - prostate
Professional memberships
